Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 30, 2020

SELL
$21.1 - $29.13 $254,149 - $350,870
-12,045 Closed
0 $0
Q2 2020

Jul 21, 2020

SELL
$18.94 - $24.93 $124,170 - $163,441
-6,556 Reduced 35.25%
12,045 $258,000
Q1 2020

Apr 27, 2020

SELL
$16.68 - $32.25 $5.8 Million - $11.2 Million
-347,501 Reduced 94.92%
18,601 $416,000
Q4 2019

Feb 04, 2020

BUY
$25.29 - $29.45 $324,951 - $378,403
12,849 Added 3.64%
366,102 $10.8 Million
Q3 2019

Nov 04, 2019

BUY
$25.62 - $34.96 $370,183 - $505,137
14,449 Added 4.26%
353,253 $9.39 Million
Q2 2019

Jul 24, 2019

BUY
$31.11 - $34.79 $550,989 - $616,165
17,711 Added 5.52%
338,804 $11.5 Million
Q1 2019

Apr 18, 2019

BUY
$29.0 - $32.83 $9.31 Million - $10.5 Million
321,093 New
321,093 $10.3 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Eastern Bank Portfolio

Follow Eastern Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eastern Bank, based on Form 13F filings with the SEC.

News

Stay updated on Eastern Bank with notifications on news.